The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Agile Therapeutics, Inc.
Investors and Encourages Investors to Contact the Firm
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors
who purchased Agile Therapeutics, Inc. (“Agile” or the “Company”) (NASDAQ: AGRX) securities between March 9, 2016 and January 3, 2017, inclusive (the “Class Period”).
Investors suffering losses on their Agile investments are encouraged to contact the Law Offices of Howard G. Smith to discuss
their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
The complaint filed in this lawsuit alleges that throughout the Class Period, Defendants made materially false and/or misleading
statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.
Specifically, Defendants failed to disclose: (1) that the Twirla contraceptive patch had an efficacy rating that fell below peer
group standards; (2) that over half of patients in its “Secure” Phase 3 Study discontinued the study early; (3) that the Twirla
patch therefore allegedly had a slight chance of FDA approval; and (4) that, as a result of the foregoing, Defendants’ statements
about Agile’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
On January 3, 2017, Agile disclosed statistical information pertaining to its Phase 3 SECURE study analyzing the Company’s
combined hormonal contraceptive patch Twirla. The study, which was initiated at the request of the FDA, comes after the FDA
rejected Agile's initial marketing application back in 2013. The Company cited "positive top-line results" in the study, yet
reported an efficacy measure that failed to meet the standard set by other approved contraceptive patches. Additionally, 51.4%
of subjects opted to discontinue the study.
On this news, Agile stock fell nearly 64% during intraday trading on January 4, 2017.
If you purchased shares of Agile during the Class Period you may move the Court no later than March 7, 2017 to
ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the Class you need not
take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If
you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or
interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol
Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email
to howardsmith@howardsmithlaw.com, or visit our website at
http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170110006177/en/